Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccinesXuexiang Han, Michael J. Mitchell, Mohamad‐Gabriel Alameh et al.|Nature Nanotechnology|2023Cited by 227
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic TropismMargaret M. Billingsley, Michael J. Mitchell, Alvin J. Mukalel et al.|Small|2023Cited by 216
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosisXuexiang Han, Michael J. Mitchell, Ningqiang Gong et al.|Nature Communications|2023Cited by 180
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone MicroenvironmentLulu Xue, Michael J. Mitchell, Ningqiang Gong et al.|Journal of the American Chemical Society|2022Cited by 170
Enhancing in situ cancer vaccines using delivery technologiesNingqiang Gong, Michael J. Mitchell, Mohamad‐Gabriel Alameh et al.|Nature Reviews Drug Discovery|2024Cited by 147